Kane Biotech Stock Price Prediction
| KNBIF Stock | USD 0.08 0.0003 0.39% |
Oversold Vs Overbought
4
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Kane Biotech based on different types of headlines from major news networks to social media. Using Kane Biotech hype-based prediction, you can estimate the value of Kane Biotech from the perspective of Kane Biotech response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Kane Biotech. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Kane Biotech to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Kane because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kane Biotech after-hype prediction price | USD 0.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kane |
Kane Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Kane Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kane Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Kane Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kane Biotech Estimiated After-Hype Price Volatility
In the context of predicting Kane Biotech's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kane Biotech's historical news coverage. Kane Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 3.32, respectively. We have considered Kane Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kane Biotech is out of control at this time. Analysis and calculation of next after-hype price of Kane Biotech is based on 3 months time horizon.
Kane Biotech OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Kane Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kane Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kane Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 3.21 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.08 | 0.08 | 3.90 |
|
Kane Biotech Hype Timeline
Kane Biotech is now traded for 0.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kane is forecasted to increase in value after the next headline, with the price projected to jump to 0.08 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 3.9%, whereas the daily expected return is now at -0.49%. The volatility of related hype on Kane Biotech is about 0.0%, with the expected price after the next announcement by competition of 0.08. Kane Biotech has accumulated 1.12 M in total debt with debt to equity ratio (D/E) of 7.12, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Kane Biotech Basic Forecasting Models to cross-verify your projections.Kane Biotech Related Hype Analysis
Having access to credible news sources related to Kane Biotech's direct competition is more important than ever and may enhance your ability to predict Kane Biotech's future price movements. Getting to know how Kane Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kane Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HESG | Health Sciences Gr | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MMIRF | MedMira | 0.00 | 0 per month | 0.00 | 0.12 | 0.77 | (0.17) | 321.49 |
Kane Biotech Additional Predictive Modules
Most predictive techniques to examine Kane price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kane using various technical indicators. When you analyze Kane charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kane Biotech Predictive Indicators
The successful prediction of Kane Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kane Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kane Biotech based on analysis of Kane Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kane Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kane Biotech's related companies.
Story Coverage note for Kane Biotech
The number of cover stories for Kane Biotech depends on current market conditions and Kane Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kane Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kane Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Kane Biotech Short Properties
Kane Biotech's future price predictability will typically decrease when Kane Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kane Biotech often depends not only on the future outlook of the potential Kane Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kane Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 114.8 M |
Complementary Tools for Kane OTC Stock analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |